Geoff Meacham

Managing director and senior research analyst covering the biopharmaceutical industry at Barclays. Previously, Meacham was with J.P.Morgan as a senior biotechnology analyst, and was an equity analyst at UBS, following early-stage biotech and life science companies. Meacham has been ranked since 2007 in the Institutional Investor poll, including a Top 3 ranking since 2008. His research coverage spans large-cap biotech companies with a global reach as well as small, development-stage companies. He also worked in the pharmaceutical industry in a research-and-development capacity, Meacham holds a PhD in molecular cell biology from UAB and a bachelor's degree in biology/microbiology from the University of Georgia.​